Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy

MLA

JanWillem Duitman, et al. “Pharmacological PAR-1 Inhibition Reduces Blood Glucose Levels but Does Not Improve Kidney Function in Experimental Type 2 Diabetic Nephropathy.” FASEB Journal, vol. 33, no. 10, Jan. 2019, pp. 10966–72. EBSCOhost, https://doi.org/10.1096/fj.201900516r.

APA

JanWillem Duitman, C. Arnold Spek, Sandrine Florquin, & Maaike Waasdorp. (2019). Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy. FASEB Journal, 33(10), 10966–10972. https://doi.org/10.1096/fj.201900516r

Chicago

JanWillem Duitman, C. Arnold Spek, Sandrine Florquin, and Maaike Waasdorp. 2019. “Pharmacological PAR-1 Inhibition Reduces Blood Glucose Levels but Does Not Improve Kidney Function in Experimental Type 2 Diabetic Nephropathy.” FASEB Journal 33 (10): 10966–72. doi:10.1096/fj.201900516r.